Answers are grounded in this paper and cite their sources.
values of 1.79 ± 0.01 μM on ZIKV and 3.01 ± 1.25 μM in WNV, supporting its relevance as a repositionable scaffold for modulation of ZIKV and WNV infections. The activity observed across flavivirus proteases highlights the value of targeting conserved allosteric regions. Overall, this integrated computer-aided drug design (CADD) strategy demonstrates the power of dynamic, structure-based pharmacophores to uncover novel allosteric inhibitors and accelerate antiviral drug repurposing.
No takes yet. Share an insight, caveat, or question.
Lupia et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: